Tissue-type plasminogen activator in the chronic subdural hematoma

Area of Science:

• Neurology
• Hematology
• Biochemistry

Background:

• Chronic subdural hematoma (CSH) is a significant neurosurgical condition.
• The exact pathophysiology of CSH persistence and enlargement remains incompletely understood.
• Tissue-type plasminogen activator (t-PA) plays a key role in fibrinolysis.

Purpose of the Study:

• To investigate the role of t-PA concentrations in the pathogenesis of CSH.
• To correlate t-PA levels with clinical severity and hematoma characteristics.
• To evaluate the changes in t-PA levels following surgical evacuation.

Main Methods:

• Measurement of t-PA concentrations in plasma and CSH fluid from 92 patients.
• Correlation of t-PA levels with clinical grades (1-5) and CT imaging findings (layer-type vs. others).
• Monitoring of t-PA levels in draining fluid post-surgery.

Main Results:

• CSH fluid t-PA levels (11.2 +/- 6.2 ng/mL) were significantly higher than normal plasma levels (4.0 +/- 1.8 ng/mL).
• Higher t-PA levels were observed in patients with severe clinical grades (stupor/coma) and layer-type hematomas.
• Post-surgical t-PA levels in draining fluid decreased, but reaccumulation occurred in some patients with increasing t-PA.

Conclusions:

• Overproduction of t-PA in CSH may initiate intermittent hemorrhage.
• t-PA contributes to the persistence and enlargement of chronic subdural hematoma.
• t-PA levels could serve as a biomarker for CSH progression and treatment response.